Furthermore, in a preclinical B-ALL xenograft model, CD19-CAR T-cells effectively controlled the growth of human pre-B ALL cells (NALM6 cells), irrespective of the presence of BM-MSCsB-ALL and BM-MSCsHD [31]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.